Cipla Readies gSymbicort, Semaglutide Amid Sale Speculation ‘Distraction’

"Very small investment” in gene editing/sequencing on cards

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.